On the Top 5 list of companies that demonstrated the most prominent growth in August there are ChemoCentryx Inc., Global Blood Therapeutics Inc., AST SpaceMobile Inc., Enovix Corporation, and Axsome Therapeutics Inc.

Selection criteria

  • Stocks are traded in NYSE and NASDAQ
  • The stock price is over $2
  • Companies are not funds
  • Capitalisation is more than $2 billion
  • Average trading statistics of the last 30 days is over 750,000 stocks.

Growth is expressed in percent as the difference between the Close price on 29 July and 31 August 2022. Market capitalisation of each company is valid for the moment when the article was being prepared.

1. ChemoCentryx – 115.8%

Founded: 1996
Registered: US
Head office: San Carlos, California
Sphere: biotech
Platform: NASDAQ
Market capitalisation: $3.7 billion

ChemoCentryx Inc. develops therapy for autoimmune, inflammatory diseases, and cancer. The company specialises in orphan and rare illnesses.

Over August, the shares of ChemoCentryx Inc. (NASDAQ:CCXI) grew by 115.8% from $23.62 to $50.98. Such impressive growth is explained by the news that the company will be acquired by a biotech giant Amgen Inc. for $3.7 billion. The parties plan to sign the agreement at the end of this year.

Share price chart of ChemoCentryx*
Share price chart of ChemoCentryx*

2. Global Blood Therapeutics – 105.7%

Founded: 2011
Registered: US
Head office: San Francisco, California
Sphere: biotech
Platform: NASDAQ
Market capitalisation: $4.6 billion

Global Blood Therapeutics Inc. develops therapy against a rare disease called sickle cell anemia. The company delivers drugs to low-income patients.

At the beginning of August it became known that Pfizer Inc. was buying Global Blood Therapeutics Inc. for $5.4 billion. This news made the shares of Global Blood Therapeutics Inc. (NASDAQ:GBT) grow abruptly: over last month, they grew by 105.7% from $32.72 to $67.89.

The agreement will let Pfizer Inc. improve its position in the market of drugs for rare hematological diseases.

Share price chart of Global Blood Therapeutics*
Share price chart of Global Blood Therapeutics*

3. AST SpaceMobile – 71%

Founded: 2017
Registered: US
Head office: Midland, Texas
Sphere: telecom services
Platform: NASDAQ
Market capitalisation: $2.2 billion

AST SpaceMobile Inc. is working on the world’s first space cellular broadband available on all smartphones. Users will be able to switch from land networks to the space one. AST SpaceMobile Inc. will be using 4G and 5G technologies.

On 9 August, the company reported that its test satellite BlueWalker 3 had arrived on cape Canaveral and was preparing to be launched to the low earth orbit. The launch is scheduled for mid-September, no exact date known yet.

On the same day, the quotes of AST SpaceMobile Inc. (NASDAQ:ASTS) grew by 9.8% to $8.29. The shares kept moving upwards for five trading sessions in a row, growing by 84.5% total. Over August, the shares of the company climbed up by 71% from $7.03 to $12.02.

In the middle of the month, AST SpaceMobile Inc. presented a report for Q2, 2022, where it demonstrated growth of earnings by 161.9% to $7.3 million, compared to the same quarter last year. Net loss dropped by 87.6% to $8.1 million, and loss per share – by 84.6% to $0.06.

Share price chart of AST SpaceMobile*
Share price chart of AST SpaceMobile*

4. Enovix – 66.1%

Founded: 2007
Registered: US
Head office: Fremont, California
Sphere: electric equipment
Platform: NASDAQ
Market capitalisation: $3.5 billion

Enovix Corporation designs, develops, and produces lithium ion batteries of new generation. The company appears on the Top 5 list of leaders of growth for the second month in a row. Over July, the shares of Enovix Corporation (NASDAQ:ENVX) grew by 49.5% from $8.91 to $13.32, and over August – by 66.1% from $13.32 to $22.12.

Analysts say that last month, such impressive growth of quotes was provoked by inspiring financial results of Q2. In April-June, earnings of Enovix Corporation amounted to $5.1 million. At the same time, net loss dropped by 92.1% to $1.1 million and loss per share – by 93% to $0.01.

Share price chart of Enovix*
Share price chart of Enovix*

5. Axsome Therapeutics – 65.3%

Founded: 2012
Registered: US
Head office: New York, New York
Sphere: biotech
Platform: NASDAQ
Market capitalisation: $2.7 billion

Axsome Therapeutics Inc. specialises in developing new methods for curing diseases of the central neural system. Its drugs help against depression, overexcitement due to Alzheimer’s disease, migraine, narcolepsy, and fibromyalgia.

Last month, the shares of Axsome Therapeutics Inc. (NASDAQ:AXSM) grew by 65.3% from $38.59 to $63.80. The biggest overnight growth happened on 19 August: that day the shares of the biotech company rose by 40.35% to $59.55.

The shares of Axsome Therapeutics Inc. reacted this way to the news that the US Food and Drug Administration (FDA) had approved of the Auvelity drug for treating major depressive disorder in adults.

Share price chart of Axsome Therapeutics*
Share price chart of Axsome Therapeutics*

Which shares demonstrated most prominent dynamics in August

In August, most noticeable growth was demonstrated by the shares of ChemoCentryx Inc., Global Blood Therapeutics Inc., AST SpaceMobile Inc., Enovix Corporation, and Axsome Therapeutics Inc. The main reasons would be good quarterly reports and agreements with other companies.

Last month, there were no leaders of falling: all companies meeting the selection criteria closed August with positive dynamics.

* – Past performance is not a reliable indicator of future results or future performance.


Material is prepared by

Server is the guru of searching for market insights. Since 2019 he writes about everything that might be useful to the investor, focusing on the stock market and its assets.